http://www.omega-pharma.be/modules/motionmill/index.php?iid=164 Sat, 04 Jul 2009 23:12:55 GMT Feed43 Proxy/1.0 (www.feed43.com) 360 a9fa0237539179354b761263477e80bf http://www.omega-pharma.be/persberichten/E_Omega_Pharma_notification_thresholds_for_participations.pdf _{-- Delivered by Feed43 service}

]]> a6e347efd3eaeb1aff0fb786d4f98e89 http://www.omega-pharma.be/persberichten/Agenda_ESM_9_June_2009_English.pdf _{-- Delivered by Feed43 service}

]]> 89d1ebd20422223e78e49b1496361322 http://www.omega-pharma.be/persberichten/volmacht_BAV_9_juni_2009_(ENG).doc _{-- Delivered by Feed43 service}

]]> eb424c6c242f079e1e46bce3add51569 http://www.omega-pharma.be/persberichten/Press_Release_Modi_Omega_Pharma_India.pdf _{-- Delivered by Feed43 service}

]]> 6b82f2f693e430a2cd8dcf1570ed6eda http://www.omega-pharma.be/persberichten/Omega_Pharma_Trading_Update_1st_quarter_2009.pdf _{-- Delivered by Feed43 service}

]]> edcaf0a6a43d0af266313370e2328ed0 http://www.omega-pharma.be/persberichten/Convocation_to_the_Annual_and_Extraordinary_General_Meeting_of_4_May_2009.pdf _{-- Delivered by Feed43 service}

]]> e0207a6e8aa197b7c9628d905691bd66 http://www.omega-pharma.be/persberichten/Proxy_Annual_General_Meeting_4_May_2009.doc _{-- Delivered by Feed43 service}

]]> fb1ec86e1e74b9f65ce2c87f29204d29 http://www.omega-pharma.be/persberichten/Proxy_Extraordinary_General_Meeting_4_May_2009.doc _{-- Delivered by Feed43 service}

]]> 2593966e6bfaa24bfb0faf60197e96c6 http://www.omega-pharma.be/persberichten/Press_Release_Omega_Pharma_FY2008_Results.pdf _{-- Delivered by Feed43 service}

]]> df328b003e6500ae46763eec1a71213c http://www.omega-pharma.be/persberichten/Omega_Pharma_Trading_Update_Q4_and_FY_2008_-_EE.pdf _{-- Delivered by Feed43 service}

]]> 4d75db2c28a3200429bf0d706a1e45e5 http://www.omega-pharma.be/persberichten/Notification_of_participation_by_Capital_Group_International.pdf _{-- Delivered by Feed43 service}

]]> c59e405535a7192f5e5bf1a99ffd0bac http://www.omega-pharma.be/persberichten/Notification_of_Capital_Group_International_17_Oct_08.pdf _{-- Delivered by Feed43 service}

]]> e95419bc90eaf914b08c4616ec6fb039 http://www.omega-pharma.be/persberichten/Notification_of_Capital_Group_International_1_Sept_08.pdf _{-- Delivered by Feed43 service}

]]> da76bc69b6ae9c1b4b3894dbdc8f8d78 http://www.omega-pharma.be/persberichten/E_Omega_Pharma_Trading_Update_Q3_2008.pdf _{-- Delivered by Feed43 service}

]]> ae5fd94b2b14260d478ba54ae6fe22cf http://www.omega-pharma.be/persberichten/E_Notification_of_shareholdings_by_Couckinvest_and_Omega_Pharma.pdf _{-- Delivered by Feed43 service}

]]> 59693ddb6f3346e82c5700aa0eeb9639 http://www.omega-pharma.be/persberichten/Kennisgeving_door_Marc_Coucke_en_Couckinvest_van_deelneming_in_Omega_Pharma_sept_08.pdf _{-- Delivered by Feed43 service}

]]> 59ad230064cf2cbe30a15e6549636c12 http://www.omega-pharma.be/persberichten/Kennisgeving_door_Omega_Pharma_van_deelneming_in_Omega_Pharma_sept_08.pdf _{-- Delivered by Feed43 service}

]]> c7f4fe47f1e15e50758bd368b757a313 http://www.omega-pharma.be/persberichten/Omega_Pharma_Investors_Day_E.pdf _{-- Delivered by Feed43 service}

]]> 6b834cb9f8dbe977e174ff70eae7235d http://www.omega-pharma.be/persberichten/Omega_Pharma_-_disclosure_in_accordance_with_the_Law_of_May_2__2007.pdf _{-- Delivered by Feed43 service}

]]> 9bd42696692de4ba79cb1b783cf678d5 http://www.omega-pharma.be/persberichten/E_Omega_Pharma_press_release_Results_First_Half_Year_2008.pdf _{-- Delivered by Feed43 service}

]]> aee40f3b8ce94a550e53c9d4542be833 http://www.omega-pharma.be/persberichten/E_Interim_Financial_Report_1H08_Omega_Pharma.pdf _{-- Delivered by Feed43 service}

]]> 8adf13ca4a2abb55137cd234bd79b314 http://www.omega-pharma.be/persberichten/E_Omega_Pharma_Trading_Update_Q2_2008.pdf _{-- Delivered by Feed43 service}

]]> 6fe77f24e6fb2138ff172478a042de2b http://www.omega-pharma.be/persberichten/Kennisgeving_Omega_Pharma_2_juli_2008.pdf _{-- Delivered by Feed43 service}

]]> bfb5f95b3a61eb161e6a0e04503b0329 http://www.omega-pharma.be/persberichten/Kennisgeving_Omega_door_Marc_Coucke_en_Couckinvest_9_juni_2008.pdf _{-- Delivered by Feed43 service}

]]> 2678be360b674378fd2115a552a11e4f http://www.omega-pharma.be/persberichten/Kennisgeving_Omega_Pharma_9_juni_2008.pdf _{-- Delivered by Feed43 service}

]]> 6ba661130c4e9c4abeaa96eb95d8f8d5 http://www.omega-pharma.be/persberichten/Agenda_ESM_9_June_2008__ENG_.pdf _{-- Delivered by Feed43 service}

]]> 9d93adfe0c0ef1874440f07a74600b33 http://www.omega-pharma.be/persberichten/Proxy_form_ESM_9_June_2008__ENG_.pdf _{-- Delivered by Feed43 service}

]]> 08de4f51b3a969a5ae9df6f86c631c3d http://www.omega-pharma.be/persberichten/Omega_Pharma_ASM_5_May_2008_presentation.pdf _{-- Delivered by Feed43 service}

]]> 09361c07fc47eac8bea89b37c1abc904 http://www.omega-pharma.be/persberichten/Brief_overview_of_the_results_of_the_voting_at_the_ASM_of_5_May_2008.pdf _{-- Delivered by Feed43 service}

]]> 7e8e412e72e28f4859a60e7231271e7b http://www.omega-pharma.be/persberichten/Minutes_selected_translation_ASM_5_May_2008.pdf _{-- Delivered by Feed43 service}

]]> 58b53026d2d608d777415159975cb33b http://www.omega-pharma.be/persberichten/E_Omega_Pharma_Trading_Update_1st_Quarter_2008.pdf _{-- Delivered by Feed43 service}

]]> 01b82b6611eace4f005e51349c176a74 http://www.omega-pharma.be/persberichten/!volmacht_JAV_5_mei_2008_(ENG).doc _{-- Delivered by Feed43 service}

]]> a5942643d95ed8a3425eee1199129fbd http://www.omega-pharma.be/persberichten/!volmacht_BAV_5_mei_2008_(ENG).doc _{-- Delivered by Feed43 service}

]]> 95bd1a14d37e6de03a0e2391e599cec5 http://www.omega-pharma.be/persberichten/Convocation_ASM_5_May_2008_l.pdf _{-- Delivered by Feed43 service}

]]> 6d9d2521fd23ec9dcb556a167c5d5085 http://www.omega-pharma.be/persberichten/E_press_release_Omega_Pharma_2007_Results.pdf _{-- Delivered by Feed43 service}

]]> 43f17f485981a88251877b4b930a5a36 http://www.omega-pharma.be/persberichten/E_Omega_Pharma_condensed_financial_statements_2007.pdf _{-- Delivered by Feed43 service}

]]> a38d3817a4118aaa139586dd29aa0524 http://www.omega-pharma.be/persberichten/E_Profile_Lucas_Laureys.pdf _{-- Delivered by Feed43 service}

]]> 5adc15ca3fe6244306f45670932be5e3 http://www.omega-pharma.be/persberichten/Omega_Pharma_-_official_notification.pdf _{-- Delivered by Feed43 service}

]]> 4af1377e8f297b33dc63dabc7b7a7433 http://www.omega-pharma.be/persberichten/Omega_Pharma_2007_turnover_grows_8_per_cent.pdf _{-- Delivered by Feed43 service}

]]> 14f79fc40335e3e10ffb088ebf2965b3 http://www.omega-pharma.be/persberichten/Information_to_the_shareholder_-_changes_in_the_denominator_in_the_course_of_2007.pdf _{-- Delivered by Feed43 service}

]]> 324f9c97edc1a4f409ea2c1375091d9b http://www.omega-pharma.be/persberichten/Kennisgeving_Omega_Pharma_eigen_aandelen_26_dec_2007.pdf _{-- Delivered by Feed43 service}

]]> 3186f743f3bd8f357dbfa8e5e67c7f45 http://www.omega-pharma.be/persberichten/Omega_Pharma_remains_cycling_sponsor_until_2011.pdf _{-- Delivered by Feed43 service}

]]> 2c6ffd9ee842e1edc0d0e9ae4dec8b79 http://www.omega-pharma.be/persberichten/Declaration_Omega_Pharma_treasury_shares_3_Dec_2007.pdf _{-- Delivered by Feed43 service}

]]> 795854c4e16ae50a77b73555bf23f61d http://www.omega-pharma.be/persberichten/Omega_Pharma_intends_to_buy_back_2_million_shares.pdf _{-- Delivered by Feed43 service}

]]> 4f17f26d177353cd3ee89679bbd1decc http://www.omega-pharma.be/persberichten/Arseus-_English_placard_greenshoe-v21.pdf _{-- Delivered by Feed43 service}

]]> dc8e2d1ee62a1df09bed9560d3d074a1 http://www.omega-pharma.be/persberichten/Omega_Pharma_Trading_Update_Q3_2007_ENGLISH.pdf _{-- Delivered by Feed43 service}

]]> 8b0cec4b7903f087b4593d4bd73b47ca http://www.omega-pharma.be/persberichten/Arseus_Press_Release_18Oct07.pdf _{-- Delivered by Feed43 service}

]]> 77aaf8769df06bf50865291943f34a61 http://www.omega-pharma.be/persberichten/Arseus_realises_successful_IPO.pdf _{-- Delivered by Feed43 service}

]]> 8056acb4b88720f561cc0611e43e7e1b http://www.omega-pharma.be/persberichten/Arseus_IPO_Result_of_the_Offering.pdf _{-- Delivered by Feed43 service}

]]> f75f711c7eeb667ddb11c607366d12a7 http://www.omega-pharma.be/persberichten/ARSEUS_250x142.pdf _{-- Delivered by Feed43 service}

]]> 9da85b77900d96bb7c2ea7fe441ebd01 http://www.omega-pharma.be/persberichten/Summary_of_declaration_of_interest_Couckinvest_Marc_Coucke_2_Oct_2007.pdf _{-- Delivered by Feed43 service}

]]> bb70096adefc22b355c1a48909bbba8f http://www.omega-pharma.be/persberichten/Arseus_IPO_-_early_closing_of_the_offering.pdf _{-- Delivered by Feed43 service}

]]> d9886009126bee40d5e5a3a888551d5c http://www.omega-pharma.be/persberichten/Press_Release_Announcement_of_price_range_Arseus_IPO.pdf _{-- Delivered by Feed43 service}

]]> ded75828fba360d4da6ded0590232c03 http://www.omega-pharma.be/persberichten/Arseus_has_assured_credit_facilities_after_IPO.pdf _{-- Delivered by Feed43 service}

]]> e61a00d99dee5a78078c7a79fa2875f1 http://www.omega-pharma.be/persberichten/E-Omega_Pharma_1H2007_financial_statement.pdf _{-- Delivered by Feed43 service}

]]> 755ec46a61924ef62271751f2467964d http://www.omega-pharma.be/persberichten/E-Omega_Pharma_1H2007_Results.pdf _{-- Delivered by Feed43 service}

]]> da2e58f090a302d8357ae572d13aa07a http://www.omega-pharma.be/persberichten/Goldman_Sachs_Group_26_July_2007.pdf _{-- Delivered by Feed43 service}

]]> b0169a42aaa206517b2cf39d16ef2092 http://www.omega-pharma.be/persberichten/Omega_Pharma_Trading_Update_Q2_S1_2007_ENGL.pdf _{-- Delivered by Feed43 service}

]]> d6c24c73b5fc7cfe0abc875cb765dd53 http://www.omega-pharma.be/persberichten/Arseus_is_accelerating_its_IPO_plan.pdf _{-- Delivered by Feed43 service}

]]> 917eddcfc884c4f8bc044d166e3bfd0d http://www.omega-pharma.be/persberichten/Agenda_ESM_6_July_2007.pdf _{-- Delivered by Feed43 service}

]]> bdf172af6fe1be86de5129511b0124e8 http://www.omega-pharma.be/persberichten/Proxy_ESM_6_July_2007.pdf _{-- Delivered by Feed43 service}

]]> 3e3102f78c4ca194ff882bdc5a4e8c5e http://www.omega-pharma.be/persberichten/Arseus_acquires_activities_of_Polichimica.pdf _{-- Delivered by Feed43 service}

]]> deba42bbe572b3de081d370fd0bfef4e http://www.omega-pharma.be/persberichten/Convocation_to_the_ASM_and_ESM_of_4_June_2007.pdf _{-- Delivered by Feed43 service}

]]> 2f5ee9f9f6390fe1243dad2884bbde22 http://www.omega-pharma.be/persberichten/Proxy_ESM_2040607.pdf _{-- Delivered by Feed43 service}

]]> 3fd9dcb1d885522d6b39f5f7e4b6a076 http://www.omega-pharma.be/persberichten/Proxy_ASM_040607.pdf _{-- Delivered by Feed43 service}

]]> c6baae359399b9a1de99e2f06e39c9b0 http://www.omega-pharma.be/persberichten/Omega_Pharma_Trading_Update_Q1_2007_en.pdf _{-- Delivered by Feed43 service}

]]> a279465dc4a402b6b173de7a14b68bdf http://www.omega-pharma.be/persberichten/Participatiemelding_Goldman_Sachs_International_18_april_2007.pdf _{-- Delivered by Feed43 service}

]]> 76e2e8f0bbc2f7c05d505d138def7c29 http://www.omega-pharma.be/persberichten/Sabbe_appointed_Executive_VP_and_De_Saedeleer_CFO_incl_Annexes.pdf _{-- Delivered by Feed43 service}

]]> 67bbcde5753be48cb19f6c097f323169 http://www.omega-pharma.be/persberichten/Omega_Pharma_acquires_Persee_Medica.pdf _{-- Delivered by Feed43 service}

]]> ec858a96e922ebfdd84296de873d989d http://www.omega-pharma.be/persberichten/persee_press_conference.pdf _{-- Delivered by Feed43 service}

]]> 7e327d3aefce6a0656ef0fa2ce1d41ca http://www.omega-pharma.be/persberichten/Corilus_is_the_new_name_for_OmegaSoft.pdf _{-- Delivered by Feed43 service}

]]> de4682fbb04c00a58cf296a43a6d6062 http://www.omega-pharma.be/persberichten/OmegaPharma_results_2006_English.pdf _{-- Delivered by Feed43 service}

]]> 76d3e0200d9ebdcc7505117bf3c5d1eb http://www.omega-pharma.be/persberichten/Resultaten_tabellen_FY_2006_ENGL.pdf _{-- Delivered by Feed43 service}

]]> 28a04e0298f9fa3ff1dbb5a5064df746 http://www.omega-pharma.be/persberichten/Analyst_meeting_1_March_2007.pdf _{-- Delivered by Feed43 service}

]]> 665d9bd505b51e98848b9eec39f9ca2a http://www.omega-pharma.be/persberichten/Predictor_the_reference_for_home_diagnostics.pdf _{-- Delivered by Feed43 service}

]]> 1f1f44809a0e8596e54fbef8801672e0 http://www.omega-pharma.be/persberichten/Omega_Pharma_maintains_IPO_scenario_for_Arseus.pdf _{-- Delivered by Feed43 service}

]]> 5981924d8798a96a7a532ce1e690a40c http://www.omega-pharma.be/persberichten/Sales_Flash_4Q06_and_FY2006_EN.pdf _{-- Delivered by Feed43 service}

]]> 3ea56870cd6162db329b8e1a6c1ccc2f http://www.omega-pharma.be/persberichten/Convocation_ESM_12_February_2007.pdf _{-- Delivered by Feed43 service}

]]> 3336aecbad9cd6734e292f2a117c5637 http://www.omega-pharma.be/persberichten/Proxy_From_ESM_12_February_2007.pdf _{-- Delivered by Feed43 service}

]]> 4d02b0d39a00c1851fa16206ee6f37d4 http://www.omega-pharma.be/persberichten/Omega_Pharma_strengthens_management.pdf _{-- Delivered by Feed43 service}

]]> 0d8cb141be63d09fc7d02036a38e10d5 http://www.omega-pharma.be/persberichten/Convocation_ESM_12_January_2007.pdf _{-- Delivered by Feed43 service}

]]> 28cd7ba8c95ae32a23e8bf19e7b9956b http://www.omega-pharma.be/persberichten/Proxy_form_ESM_12_January_2007.pdf _{-- Delivered by Feed43 service}

]]> f171bdd0de7a527d015af958d3968800 http://www.omega-pharma.be/persberichten/Omega_Pharma_Results_3rd_quarter_2006.pdf _{-- Delivered by Feed43 service}

]]> 47e13b98d6e725ef93a7c303d8ba76aa http://www.omega-pharma.be/persberichten/Omega_Pharma_-_Convocation_Extraordinary_Shareholder_Meeting_14_Dec_2006.pdf _{-- Delivered by Feed43 service}

]]> d8879bf4c233c81204476a7daf6b7a27 http://www.omega-pharma.be/persberichten/Proxy_ESM_Omega_Pharma_14_Dec_2006.pdf _{-- Delivered by Feed43 service}

]]> 5bc1618436710e87ce18e5e513e3d804 http://www.omega-pharma.be/persberichten/Omega_Pharma_to_repeat_Davitamon_sponsoring_success_with_Predictor.pdf _{-- Delivered by Feed43 service}

]]> ed8ad1d2b4e707869b7b5c13b164439f http://www.omega-pharma.be/persberichten/Omega_Pharma_acquires_Bittner_Pharma_Group.pdf _{-- Delivered by Feed43 service}

]]> f717c1572686506a268f3c9b4c0287f7 http://www.omega-pharma.be/persberichten/Sales_Flash_3rd_quarter_2006.pdf _{-- Delivered by Feed43 service}

]]> b5ecd91d62bfe2cb77665909ded96a66 http://www.omega-pharma.be/persberichten/New_OmegaPharma_CEO.pdf _{-- Delivered by Feed43 service}

]]> 79ba524fdacd07edb4d8289d77263ace http://www.omega-pharma.be/persberichten/Profile_Jan_Cassiman.pdf _{-- Delivered by Feed43 service}

]]> a55be456b0efdbd5cd24188f9869a324 http://www.omega-pharma.be/persberichten/OmegaPharma_results_1st_halfyear2006.pdf _{-- Delivered by Feed43 service}

]]> 13197727ca941ce03ae0a5d4456f0ecb http://www.omega-pharma.be/persberichten/OmegaPharma_financialstatement_1sthalf2006.pdf _{-- Delivered by Feed43 service}

]]> c885030b4817ea5a37d672c61a69d8b0 http://www.omega-pharma.be/persberichten/Sales_Flash_Omega_Pharma_2nd_quarter_2006.pdf _{-- Delivered by Feed43 service}

]]> 48d5b5cbc72b2a482d1c1cc8c080b530 http://www.omega-pharma.be/persberichten/cancellation_shares.pdf _{-- Delivered by Feed43 service}

]]> 2fc9e48e6302f738bb503c9f7797dd8a http://www.omega-pharma.be/persberichten/2006_06_16_Agenda_ESM_6_June_2006.pdf _{-- Delivered by Feed43 service}

]]> c9bacad527c2d8034b706a3e4019189c http://www.omega-pharma.be/persberichten/Omega_Pharma_presents_Arseus.pdf _{-- Delivered by Feed43 service}

]]> 814d60a6990073b7f7e545554e13df83 http://www.omega-pharma.be/persberichten/Omega_Pharma_Results_Q1_2006_ENGL.pdf _{-- Delivered by Feed43 service}

]]> 9e63caffdcd63de035f8abb5e8183e96 http://www.omega-pharma.be/persberichten/Omega_Pharma_plans_acquisition_of_Bional_group.pdf _{-- Delivered by Feed43 service}

]]> fdcf1ed367d35f37764908db20cedc00 http://www.omega-pharma.be/persberichten/Convocation_ASM_ESM_6_June_2006.pdf _{-- Delivered by Feed43 service}

]]> 3c682936a22d78d622a51cd437c9170f http://www.omega-pharma.be/persberichten/Omega_Pharma_in_European_OTC_alliance.pdf _{-- Delivered by Feed43 service}

]]> 1de0e6f2ec40032120eb307b9ad35cbf http://www.omega-pharma.be/persberichten/Omega_Pharma_sales_flash_1Q2006.pdf _{-- Delivered by Feed43 service}

]]> 4a3c08e9c99a12240bbc1c57d8c33dd2 http://www.omega-pharma.be/persberichten/2006_03_16_Results_2005.pdf _{-- Delivered by Feed43 service}

]]> bd303f39d4ba37e3e50a82dace91d765 http://www.omega-pharma.be/persberichten/2006_01_12_Sales_flash_2005.pdf _{-- Delivered by Feed43 service}

]]>